| Literature DB >> 28036084 |
Daniel Santos1,2, Francisco González-Pérez3,4, Guido Giudetti5, Silvestro Micera6,7, Esther Udina8,9, Jaume Del Valle10,11, Xavier Navarro12,13.
Abstract
After peripheral nerve injury, motor and sensory axons are able to regenerate but inaccuracy of target reinnervation leads to poor functional recovery. Extracellular matrix (ECM) components and neurotrophic factors (NTFs) exert their effect on different neuronal populations creating a suitable environment to promote axonal growth. Here, we assessed in vitro and in vivo the selective effects of combining different ECM components with NTFs on motor and sensory axons regeneration and target reinnervation. Organotypic cultures with collagen, laminin and nerve growth factor (NGF)/neurotrophin-3 (NT3) or collagen, fibronectin and brain-derived neurotrophic factor (BDNF) selectively enhanced sensory neurite outgrowth of DRG neurons and motor neurite outgrowth from spinal cord slices respectively. For in vivo studies, the rat sciatic nerve was transected and repaired with a silicone tube filled with a collagen and laminin matrix with NGF/NT3 encapsulated in poly(lactic-co-glycolic acid) (PLGA) microspheres (MP) (LM + MP.NGF/NT3), or a collagen and fibronectin matrix with BDNF in PLGA MPs (FN + MP.BDNF). Retrograde labeling and functional tests showed that LM + MP.NGF/NT3 increased the number of regenerated sensory neurons and improved sensory functional recovery, whereas FN + MP.BDNF preferentially increased regenerated motoneurons and enhanced motor functional recovery. Therefore, combination of ECM molecules with NTFs may be a good approach to selectively enhance motor and sensory axons regeneration and promote appropriate target reinnervation.Entities:
Keywords: BDNF; NGF; NT3; extracellular matrix; motor axons; nerve regeneration; neurotrophic factors; reinnervation; sensory axons
Mesh:
Substances:
Year: 2016 PMID: 28036084 PMCID: PMC5297700 DOI: 10.3390/ijms18010065
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1(A–I) RT97 stained neurites from spinal cord slices cultured within a 3D collagen matrix alone, and with addition of NGF/NT3 or brain-derived neurotrophic factor (BDNF) (A–C); with 20% laminin, plus NGF/NT3 or BDNF (D–F); and with 20% fibronectin, plus NGF/NT3 or BDNF (G–I); plots representing maximum neurite length in the different DRG culture conditions (J); quantification of the number of neurites grown at increasing distance from the DRG body, dashed line represents the values for COL control group (100%) (K); and plots of the quantified area under each curve of K graph (L). Data expressed as mean ± SEM. * p < 0.05 and *** p < 0.001.
Figure 2(A–I) RT97 stained neurites from DRG neurons cultured within a 3D collagen matrix alone, and with addition of NGF/NT3 or BDNF (A–C); with 20% laminin, plus NGF/NT3 or BDNF (D–F); and with 20% fibronectin, plus NGF/NT3 or BDNF (G–I); (J) plots representing maximum neurite length in the different culture conditions, dashed line represents the values for COL control group (100%); (K) quantification of the number of neurites grown at increasing distance from the cord slice; and (L) plots of the quantified area under each curve of K graph. Data expressed as mean ± SEM. * p < 0.05, ** p < 0.01 and *** p < 0.001.
Figure 3(A–F) Representative micrographs of neurons retrolabeled with FG in the spinal cord (A–C); and DRG (D–F) of rats after sciatic nerve section and repair with a nerve conduit filled: with COL (A,D); LM + MP.NGF/NT3 (B,E); or FN + MP.BDNF (C,F). (G–H) Histogram of the number of regenerated motor neurons in the spinal cord (G) and sensory neurons in the DRG (H) in the short term (20 days after injury) study. (I,J) Histogram of the number of regenerated motor neurons in the spinal cord (I) and sensory neurons in the DRG (J) after application of FG retrotracer at the ankle level 75 days after injury. Data expressed as mean ± SEM. * p < 0.05, ** p < 0.01 and *** p < 0.001.
Figure 4FN + MP.BDNF and LM + MP.NGF/NT3 enhance motor and sensory functional recovery, respectively. (A,B) Mean amplitude of the CMAP in TA (A) and PL (B) muscles during follow-up. ** p < 0.01 and *** p < 0.001 FN + MP.BDNF vs. all other groups referenced by the color of the star. (C) Pinprick score in the different groups during follow-up; * p < 0.05. (D) Latency of withdrawal response to thermal stimuli in the lateral part of the paw during follow-up; ** p < 0.01 and *** p < 0.001 LM + MP.NGF/NT3 vs. all other groups referenced by the color of the star. (E–J) Representative images of plantar pads immunolabeled against PGP in: an intact rat (E); COL (F); LM (G); LM + MP.NGF/NT3 (H); FN (I); and FN + MP.BDNF (J) treated animals. Insets: Detail of axons stained with PGP innervating epidermis and SGs. (K,L) Percentage of reinnervated IENF (K) and reinnervated SGs (L) vs. intact values. * p < 0.05, ** p <0.01 and *** p < 0.001. Data is presented as mean ± SEM.
Experimental conditions evaluated in the in vitro and in vivo studies.
| Group | Abbreviation | N | Description |
|---|---|---|---|
|
| |||
| Collagen | COL | 8 | Collagen type I (3 mg/mL) gel |
| Collagen + NGF/NT3 | COL + NGF/NT3 | 7 | Collagen type I (3 mg/mL) gel supplemented with NGF and NT3 (25 + 25 ng/mL) |
| Collagen + BDNF | COL + BDNF | 6 | Collagen type I (3 mg/mL) gel supplemented with BDNF (50 ng/mL) |
| Laminin | LM | 8 | Collagen type I (3 mg/mL) gel containing 20% laminin type I |
| Laminin + NGF/NT3 | LM + NGF/NT3 | 7 | Collagen type I (3 mg/mL) gel containing 20% laminin type I and NGF + NT3 (25 + 25 ng/mL) |
| Laminin + BDNF | LM + BDNF | 7 | Collagen type I (3 mg/mL) gel containing 20% laminin type I and BDNF (50 ng/mL) |
| Fibronectin | FN | 6 | Collagen type I (3 mg/mL) gel containing 20% fibronectin |
| Fibronectin + NGF/NT-3 | FN + NGF/NT3 | 6 | Collagen type I (3 mg/mL) gel containing 20% fibronectin and NGF + NT3 (25 + 25 ng/mL) |
| Fibronectin + BDNF | FN + BDNF | 7 | Collagen type I (3 mg/mL) gel containing 20% fibronectin and BDNF (50 ng/mL) |
| Collagen | COL | 6 | Collagen type I (3 mg/mL) gel |
| Laminin | LM | 6 | Collagen type I (3 mg/mL) gel containing 20% laminin type I |
| Collagen + NGF/NT3 * | MP.NGF/NT3 | 6 | Collagen type I (3 mg/mL) gel containing NGF + NT3 (1 + 1 µg/mL) encapsulated in PLGA microspheres |
| Laminin + NGF/NT3 | LM + MP.NGF/NT3 | 6 | Collagen type I (3 mg/mL) gel containing 20% laminin type I and NGF + NT3 (1 + 1 µg/mL) encapsulated in PLGA microspheres |
| Fibronectin | FN | 6 | Collagen type I (3 mg/mL) gel containing 20% fibronectin |
| Collagen + BDNF * | MP.BDNF | 6 | Collagen type I (3 mg/mL) gel containing 2 µg/mL of BDNF encapsulated in PLGA microspheres |
| Fibronectin + BDNF | FN + MP.BDNF | 6 | Collagen type I (3 mg/mL) gel containing 20% fibronectin and 2 µg/ml of BDNF encapsulated in PLGA microspheres |
* Only in the short term study.